# LENZ Therapeutics, Inc.: Form SC 13D/A, filed Nov 8, 2024

- Company: [LENZ Therapeutics, Inc.](/companies/lenz.md) (CIK 1815776)
- Form: SC 13D/A
- Filed: 2024-11-08
- Accepted by EDGAR: Nov 8, 2024, 17:08 ET
- Period: not reported
- Accession: 0001193125-24-254239
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1815776/000119312524254239/d871919dsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1815776/000119312524254239/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1815776/000119312524254239/d871919dsc13da.htm

Filed Nov 8, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-254239. Last ingested by Listed: Nov 5, 2026, 13:56 ET. No prices; not investment advice.